Fit-for-Purpose COA Development: 25 years developing, modifying and validating PROs in more than 60 therapeutic categories. LEARN MORE

QualityMetric is now an IQVIA Business: click here for more information on the IQVIA COAs available for licensing

Translation Services: 25 years developing linguistically validated translations of COAs, CRFs, protocols, manuals, etc… READ MORE

QualityMetric By The Numbers: 53,000,000+ Global Survey administrations, 48,000+ Peer-reviewed articles across 100+ conditions, 200+ Language translations by mode of administrations, 100+ Condition-Specific, Country-Specific, and Insurance Claims Benchmarks General Population Norms. Which survey should you use? SEE OUR SUITE OF PRO SURVEYS

ePRO & EDC Integration: Seamless integration for optimal efficiencies using Web Service Application Programming Interface (API), Single Sign-on Access (SSO) or Electronic-Friendly Survey Administration. FIND OUT HOW

HIT-6 NEW COAS IN ONCOLOGY GUIDE

QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.

Read the Guide

QualityMetric’s Pediatric PRO Health Surveys

Give a voice to children and adolescents from five to eighteen years of age when assessing health-related quality of life. Access a wide selection of pediatric PRO measures to advance patient health in both clinical research and care settings.

QualityMetric’s pediatric-specific PRO health surveys capture, analyze and interpret health outcomes for a variety of conditions by coupling meaningful data with multidisciplinary research expertise to gain a deeper understanding of pediatric patient experiences and preferences.

Our suite of pediatric PRO measures include several HealthActCHQ instruments that provide scientifically validated insights commonly utilized in pharmaceutical clinical trials, government studies, and academic research. Examine health status for the full age continuum of populations by leveraging versatile pediatric assessments in your work.

Contact us for a review of our capabilities by phone at (800) 572-9394 or by filling out the form. For academic organizations click here.

BACK

Select the organization that best describes your company:

Survey License Application

Please answer the following questions and we will be in touch regarding your license

Thank you for your request.

QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.

Next steps:

If you have started administering the survey, please email a copy of the survey being administered to [email protected]. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).

If you are applying for a student license, please email a copy of your student ID to [email protected].

Our Suite of Pediatric Solutions

Available in over 200 languages across multiple modes of administration, our pediatric patient-reported outcome surveys help researchers and investigators integrate the voice of adolescents, children, toddlers and infants in studies and trials around the globe, giving a voice to children and their families across hundreds of disease conditions and studies. In addition to QualityMetric’s core pediatric experience, we recently added HealthActCHQ‘s portfolio of internationally recognized child and infant patient-reported outcome (PRO) legacy measures to further expand the patients’ perspectives in healthcare planning.


Pediatric-Specific PRO Surveys

For assessing quality of life and functional health and well-being across all conditions ages infant to eighteen.


With a trusted network of linguists and translators offering extensive knowledge in end-to-end drug development and country-specific guidelines, we can facilitate intended translation interpretations for all target populations and enable an unbaised view of health outcomes and study results.

The principal surveys from our observer-reported (ObsRO) toolkit portfolio include the Child Health Questionnaire (CHQ) and the Infant Toddler Quality of Life (ITQOL)—legacy surveys focused on pediatric and adolescent health-related quality of life (HRQOL). These comprehensive measures assess the infant, child or adolescent’s physical, emotional and social well-being from the parent’s perspective and also capture the overall well-being of the parent and family. As recommended by the FDA, EMA, NICE and others, the CHQ is also available as a self-reported PRO measure.

Fit-for-Purpose Surveys

For measurement relevant to patients’ unique experience of their disease and treatment with evidence of reliability, validity and the ability to detect change in the underlying disease.

Custom PRO Surveys

For measurement that is specific to your project or condition-related goals, whether you require an entirely new PRO survey or modifications to an existing survey.

Learn More

Bibliography

A comprehensive list of peer-reviewed manuscripts documenting the use of several pediatric-specific PRO health surveys from HealthActCHQ.

View Now

Expertise in over 60 therapeutic areas.

Comprised of multidisciplinary scientists, researchers and health experts around the globe, our team has decades of experience in diverse therapeutic areas, including:

Rare Disease
Immunology
Oncology
Behavioral Health
Chronic Diseases

Enhancing your decision-making processes

Our high-quality, regulatory-compliant data will better inform your processes and improve your ability to address health-related outcomes.

DRUG PERFORMANCE

For measurement relevant to patients’ unique experience of their disease and treatment with evidence of reliability, validity and the ability to detect change in the underlying disease.

DISEASE BURDEN

Understand the full impact of diseases on patients and defined populations.

COMPARATIVE EFFECTIVENESS

Make risk-adjusted comparisons across treatments, providers, programs and patients.

PATIENT LIFECYCLE

Evaluate unmet needs and identify opportunities to increase the length and quality of patients’ lives.

FUTURE RISKS

Predict the future health utilization and medical expenditures of certain patients.

HEALTH FLUCTUATION

Measure and monitor health improvement or decline as well as the velocity of change over time.

LABEL CLAIMS

Incorporate the patient’s experience in product label and marketing claims.

Benefiting the product lifecycle

Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.

Commercial
Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Phase I
Assist with PRO/COA and clinical end development; outcome measures selection; the review and synthesis of evidence for specific measures; and the development and psychometric evaluation of new measures for testing in Phase II.
Phase II
Assist with preparation for End of Phase 2 meetings; COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase III
Assist with COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase IV
Assist with strategy, design, endpoints, and analysis for real-world studies; Electronic Data Capture solution for real-world studies; analysis and interpretation of PRO results; Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Registries
Develop measurement strategy that contributes to the body of evidence for all stakeholders. Characterize and quantify treatment benefit using PRO, ClinRO, ObsRO.
Benefiting the product lifecycle

Our PRO solutions can provide continuity in measurement across the continuum of product development, helping fill in gaps in clinical markers.

Commercial
Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Phase I
Assist with PRO/COA and clinical end development; outcome measures selection; the review and synthesis of evidence for specific measures; and the development and psychometric evaluation of new measures for testing in Phase II.
Phase II
Assist with preparation for End of Phase 2 meetings; COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase III
Assist with COA/PRO-related label claims language and supporting documentation; study design and analysis plans; analysis and interpretation of data from PROs, ObsROs, and ClinROs; synthesis and collection of evidence into PRO Dossiers; support on publications and manuscripts.
Phase IV
Assist with strategy, design, endpoints, and analysis for real-world studies; Electronic Data Capture solution for real-world studies; analysis and interpretation of PRO results; Dissemination to stakeholders, including payers, providers and consumers; deploy PROs and real-time messaging via branded or unbranded websites; support on publications and manuscripts.
Registries
Develop measurement strategy that contributes to the body of evidence for all stakeholders. Characterize and quantify treatment benefit using PRO, ClinRO, ObsRO.